Gulam Manji, MD
Columbia University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Gulam Manji, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:38 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06048484 · Combination Therapy in Patients With Localized Pancreatic Ductal AdenocarcinomaGulam Manji · recruiting · Pancreatic Ductal Adenocarcinoma · principal investigator
- Ph2NCT04543071 · Chemo4METPANC Combination Chemokine Inhibitor, Immunotherapy, and Chemotherapy in Pancreatic AdenocarcinomaColumbia University · active not recruiting · Pancreatic Cancer, Adenocarcinoma of the Pancreas, Adenocarcinoma · principal investigator
- N/ANCT04476537 · RNA Precision Oncology in Advanced Pancreatic CancerColumbia University · terminated · Pancreatic Cancer · principal investigator
- Ph1/Ph2NCT04214418 · Study of Combination Therapy With the MEK Inhibitor, Cobimetinib, Immune Checkpoint Blockade, Atezolizumab, and the AUTOphagy Inhibitor, Hydroxychloroquine in KRAS-mutated Advanced MalignanciesColumbia University · terminated · Gastrointestinal Cancer · principal investigator
- Ph2NCT03979066 · Study Evaluating NEOadjuvant Immunotherapy in Resectable PANCreatic Ductal AdenocarcinomaGulam Manji · terminated · Pancreatic Ductal Adenocarcinoma · principal investigator
- Ph2NCT02918162 · Perioperative Chemo and Pembrolizumab in Gastric CancerGulam Manji · completed · Gastric Cancer, Adenocarcinoma of the Gastroesophageal Junction · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:38 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.